These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7713201)

  • 1. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society.
    Boe J; Bakke P; Rødølen T; Skovlund E; Gulsvik A
    Eur Respir J; 1994 Dec; 7(12):2179-84. PubMed ID: 7713201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group.
    Barnes NC; Marone G; Di Maria GU; Visser S; Utama I; Payne SL
    Eur Respir J; 1993 Jun; 6(6):877-85. PubMed ID: 8339809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluticasone propionate 1 mg daily and beclomethasone dipropionate 2 mg daily: a comparison over 1 yr.
    Lorentzen KA; Van Helmond JL; Bauer K; Langaker KE; Bonifazi F; Harris TA
    Respir Med; 1996 Nov; 90(10):609-17. PubMed ID: 8959118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluticasone propionate 750 micrograms/day versus beclomethasone dipropionate 1500 micrograms/day: comparison of efficacy and adrenal function in paediatric asthma.
    Fitzgerald D; Van Asperen P; Mellis C; Honner M; Smith L; Ambler G
    Thorax; 1998 Aug; 53(8):656-61. PubMed ID: 9828851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
    Pauwels RA; Yernault JC; Demedts MG; Geusens P
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.
    Barnes NC; Hallett C; Harris TA
    Respir Med; 1998 Jan; 92(1):95-104. PubMed ID: 9519232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled beclomethasone dipropionate suppresses the hypothalamo-pituitary-adrenal axis in a dose dependent manner.
    Grebe SK; Feek CM; Durham JA; Kljakovic M; Cooke RR
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):297-304. PubMed ID: 9373450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
    Gustafsson P; Tsanakas J; Gold M; Primhak R; Radford M; Gillies E
    Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of triamcinolone acetonide MDI with a built-in tube extender and beclomethasone dipropionate MDI in adult asthmatics.
    Berkowitz R; Rachelefsky G; Harris AG; Chen R
    Chest; 1998 Sep; 114(3):757-65. PubMed ID: 9743163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.
    Anderson PB; Langley SJ; Mooney P; Jones J; Addlestone R; Rossetti A; Cantini L
    J Investig Allergol Clin Immunol; 2002; 12(2):107-13. PubMed ID: 12371526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the efficacy and safety of a half dose of fluticasone propionate with beclamethasone dipropionate and budesonide in childhood asthma.
    Karakoç F; Karadag B; Kut A; Ersu R; Bakaç S; Cebeci D; Dagli E
    J Asthma; 2001 May; 38(3):229-37. PubMed ID: 11392363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group.
    Dahl R; Lundback B; Malo JL; Mazza JA; Nieminen MM; Saarelainen P; Barnacle H
    Chest; 1993 Nov; 104(5):1352-8. PubMed ID: 8222787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
    Fowler SJ; Currie GP; Lipworth BJ
    J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler.
    Lundback B; Alexander M; Day J; Hebert J; Holzer R; Van Uffelen R; Kesten S; Jones AL
    Respir Med; 1993 Nov; 87(8):609-20. PubMed ID: 8290745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
    J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of beclometasone dipropionate and fluticasone propionate suspensions for nebulization in adult patients with persistent asthma.
    Terzano C; Ricci A; Burinschi V; Nekam K; Lahovsky J
    Respir Med; 2003 Feb; 97 Suppl B():S35-40. PubMed ID: 12593526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone.
    Malo JL; Cartier A; Ghezzo H; Mark S; Brown J; Laviolette M; Boulet LP
    Eur Respir J; 1999 May; 13(5):993-8. PubMed ID: 10414395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
    Lee DK; Bates CE; Currie GP; Cowan LM; McFarlane LC; Lipworth BJ
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):253-8. PubMed ID: 15478385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma.
    Heinig JH; Boulet LP; Croonenborghs L; Möllers MJ
    Respir Med; 1999 Sep; 93(9):613-20. PubMed ID: 10542974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.